As of September 2026 Inhibikase Therapeutics has a market cap of $0.33 Billion USD. This makes Inhibikase Therapeutics the world's 8348th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.